Want to see CH:BION full AI Analyst Report?

BB Biotech (BION) Financial Statements

8 Followers

BB Biotech Financial Overview

BB Biotech's market cap is currently CHF2.66B. The company's EPS TTM is CHF-8.02; its P/E ratio is -9.47; and it has a dividend yield of 3.95%. BB Biotech is scheduled to report earnings on April 24, 2026, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	CHF 76.81M	CHF 111.63M	CHF 35.00K	CHF 4.00K	CHF -396.22M
Gross Profit	CHF 76.76M	CHF 111.63M	CHF 35.00K	CHF 4.00K	CHF -396.22M
Operating Income	CHF 586.83M	CHF 84.40M	CHF -29.93M	CHF -38.62M	CHF -52.59M
EBITDA	CHF 578.64M	CHF 80.33M	CHF -34.60M	CHF -43.01M	CHF -59.20M
Net Income	CHF 578.13M	CHF 75.90M	CHF -206.61M	CHF -357.81M	CHF -404.81M
Balance Sheet
Cash & Short-Term Investments	CHF 99.41M	CHF 2.41B	CHF 2.64B	CHF 3.05B	CHF 3.64B
Total Assets	CHF 2.79B	CHF 2.41B	CHF 2.64B	CHF 3.05B	CHF 3.64B
Total Debt	CHF 0.00	CHF 117.50M	CHF 304.90M	CHF 363.00M	CHF 355.00M
Net Debt	CHF -98.22M	CHF 117.04M	CHF 304.40M	CHF 361.05M	CHF 352.17M
Total Liabilities	CHF 6.97M	CHF 121.11M	CHF 313.94M	CHF 367.25M	CHF 355.00M
Stockholders' Equity	CHF 2.78B	CHF 2.29B	CHF 2.32B	CHF 2.69B	CHF 3.28B
Cash Flow
Free Cash Flow	CHF 309.14M	CHF 304.56M	CHF 218.28M	CHF -357.81M	CHF -94.79M
Operating Cash Flow	CHF 309.14M	CHF 304.56M	CHF 218.28M	CHF -357.81M	CHF -94.79M
Investing Cash Flow	CHF 0.00	CHF 0.00	CHF 0.00	CHF 588.94M	CHF 0.00
Financing Cash Flow	CHF -203.19M	CHF -305.20M	CHF -220.21M	CHF -233.27M	CHF 91.77M

Currency in CHF

BB Biotech Earnings and Revenue History

Income Statement >

BB Biotech Debt to Assets

Balance Sheet >

BB Biotech Cash Flow

Cash Flow >

BB Biotech Forecast EPS vs Actual EPS

Earnings >